Suchergebnisse - "Tauopathies"

PubPharm (3.114)

1

Generation of tau dephosphorylation-targeting chimeras for the treatment of Alzheimer's disease and related tauopathies

enthalten in: Science bulletin | 2024

von Su, J. | Xiao, Y. | Wei, L. | +11

2

Novel Insights into the Genetic Basis of Progressive Supranuclear Palsy in Asian-Indian Population

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2024

von Dey, S. | Debnath, M. | Yelamanchi, R. | +7

3

Functional Selection of Tau Oligomerization-Inhibiting Aptamers

enthalten in: Angewandte Chemie (International ed. in English) | 2024

von Wang, B. | Pan, X. | Teng, I. | +17

4

Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15 : Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15

enthalten in: ClinicalTrials.gov | 2024

5

How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?

enthalten in: Expert opinion on pharmacotherapy | 2024

von Lozupone, M. | Dibello, V. | Daniele, A. | +3

6

Accelerated sarcopenia precedes learning and memory impairments in the P301S mouse model of tauopathies and Alzheimer's disease

enthalten in: Journal of cachexia, sarcopenia and muscle | 2024

von Longo, S. | Messi, M. | Wang, Z. | +2

7

SORL1 is a receptor for tau that promotes tau seeding

enthalten in: The Journal of biological chemistry | 2024

von Cooper, J. | Lathuiliere, A. | Su, E. | +10

8

Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R

enthalten in: Cell communication and signaling : CCS | 2024

von Ackmann, J. | Brüge, A. | Gotina, L. | +7

9

Structural determinants for activation of the Tau kinase CDK5 by the serotonin receptor 5-HT7R

enthalten in: Cell communication and signaling | 2024

von Ackmann, J. | Brüge, A. | Gotina, L. | +7

10

Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503 : Center Without Walls for Imaging Proteinopathies With PET (CW2IP2): Phase I Pilot Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-M503

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[312]